47 studies found for:    Acid Lipase Disease
Show Display Options
Rank Status Study
21 Completed Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease
Conditions: Obesity;   Nonalcoholic Fatty Liver Disease
Interventions: Dietary Supplement: Resveratrol;   Other: Placebo
22 Suspended Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
23 Completed Comparison of MAG and Fish Oil Efficacy
Condition: Obesity
Interventions: Dietary Supplement: Fish oil enriched with EPA;   Dietary Supplement: MAG-EPA oil;   Drug: Orlistat
24 Completed
Has Results
Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects
Condition: HIV Infections
Intervention: Drug: Tipranavir
25 Completed
Has Results
A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: fosamprenavir (GW433908);   Drug: ritonavir
26 Unknown  Lovaza Mechanisms of Action
Condition: Moderate Hypertriglyceridemia.
Intervention: Dietary Supplement: Omega 3 fatty acid (Lovaza)
27 Terminated Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants
Condition: Prevention of Growth Restriction
Interventions: Drug: rhBSSL (recombinant human bile-salt-stimulated lipase);   Drug: Placebo
28 Terminated A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Dietary Supplement: Conjugated Linoleic Acid;   Drug: Conjugated Linoleic Acid
29 Unknown  Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]
Condition: Familial Lipoprotein Lipase Deficiency
Interventions: Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X];   Drug: Mycophenolate mofetil;   Drug: cyclosporine
30 Terminated Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies
Condition: Hyperlipoproteinemia Type I
31 Completed
Has Results
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF);   Drug: raltegravir (RAL)
32 Completed Following Lipectomy to Understand Adipose Tissue Re-accumulation
Conditions: Menopause;   Pre-menopause
Intervention: Procedure: Femoral lipectomy
33 Completed Substrate Cycling in Energy Metabolism
Conditions: Burns;   Insulin Resistance
Intervention: Drug: fenofibrate
34 Recruiting Thiopurine Induced Pancreatitis in IBD Patients
Conditions: Pancreatitis;   Inflammatory Bowel Diseases
Intervention: Drug: Azathioprine
35 Completed
Has Results
Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine
Condition: Advanced Melanoma
Interventions: Drug: Ipilimumab;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Dacarbazine
36 Unknown  Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue
Condition: Breast Cancer
Intervention: Drug: Conjugated Linoleic Acid (CLA)
37 Completed
Has Results
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir
38 Completed Comparative Effects of 2 Diets in Veterans With the Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Dietary Supplement: MUFA MOVE! (Monounsaturated fatty enriched diet);   Dietary Supplement: PUFA MOVE! (Polyunsaturated fatty acid enriched diet)
39 Completed Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function
Conditions: Diabetes Mellitus, Type 2;   Cardiomyopathy, Dilated
Interventions: Drug: Acipimox;   Drug: Cellulosum Mycrocryst
40 Completed Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects
Condition: Familial Lipoprotein Lipase Deficiency
Interventions: Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X];   Drug: mycophenolate mofetil;   Drug: cyclosporine;   Drug: methylprednisolone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results    Last Page
Indicates status has not been verified in more than two years